» Articles » PMID: 9242373

EGF Induced SOS Phosphorylation in PC12 Cells Involves P90 RSK-2

Overview
Journal Oncogene
Date 1997 Jul 24
PMID 9242373
Citations 70
Authors
Affiliations
Soon will be listed here.
Abstract

SOS, the guanine nucleotide exchange factor for Ras, becomes phosphorylated on serine and threonine residues following stimulation of cells with growth factors. These phosphorylations may play a role in negative feedback of Ras stimulation and have been shown to be mediated in part by the MAP kinases Erk-1 and Erk-2. Here we show that in addition to MAP kinase, a major mitogen activated kinase for SOS is p90 Rsk-2, a downstream target of MAP kinase. p90 Rsk-2 phosphorylates SOS in an in gel assay and also in solution in vitro. The ability of p90 Rsk-2 to phosphorylate SOS increases greatly following EGF treatment of PC12 cells and is blocked by expression of N17 Ras or treatment with the MEK inhibitor PD98059. Phosphopeptide mapping revealed that the sites phosphorylated by p90 Rsk-2 in vitro were also phosphorylated in intact cells in response to EGF treatment. Several major sites of in vivo phosphorylation correlated with p90 Rsk-2 phosphorylation sites rather than MAP kinase sites. It is therefore likely that p90 Rsk-2 plays an important role in the down regulation of the Ras activation pathway through SOS.

Citing Articles

MEK inhibitors: a promising targeted therapy for cardiovascular disease.

Mohammed K, Madeddu P, Avolio E Front Cardiovasc Med. 2024; 11:1404253.

PMID: 39011492 PMC: 11247000. DOI: 10.3389/fcvm.2024.1404253.


Combinatorial strategies to target RAS-driven cancers.

Perurena N, Situ L, Cichowski K Nat Rev Cancer. 2024; 24(5):316-337.

PMID: 38627557 DOI: 10.1038/s41568-024-00679-6.


Therapeutic targeting of p90 ribosomal S6 kinase.

Wright E, Lannigan D Front Cell Dev Biol. 2024; 11:1297292.

PMID: 38169775 PMC: 10758423. DOI: 10.3389/fcell.2023.1297292.


Navigating the ERK1/2 MAPK Cascade.

Martin-Vega A, Cobb M Biomolecules. 2023; 13(10).

PMID: 37892237 PMC: 10605237. DOI: 10.3390/biom13101555.


Phosphorylation-Assisted Luciferase Complementation Assay Designed to Monitor Kinase Activity and Kinase-Domain-Mediated Protein-Protein Binding.

Poti A, Denes L, Papp K, Bato C, Banoczi Z, Remenyi A Int J Mol Sci. 2023; 24(19).

PMID: 37834301 PMC: 10573712. DOI: 10.3390/ijms241914854.